HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Interferon gamma as an immunological strategy for the treatment of human leishmaniasis].

Abstract
T lymphocytes from patients with visceral leishmaniasis treated in vitro with leishmania antigens are unable to proliferate and to produce gamma interferon. These patients have negative specific skin tests. Opposite results are obtained in patients with another clinical form of the disease named mucocutaneous leishmaniasis, in which both tests are positive. Nevertheless, patients with visceral leishmaniasis or mucocutaneous leishmaniasis, refractory to chemotherapy (antimonium complex), were cured when treated with antimonium in combination with gamma interferon, in spite of different immunological profiles. Different interpretative hypotheses of the reversion of chemoresistance induced by gamma interferon are discussed.
AuthorsE Falcoff, L A Giménez, J G Bernabó, O Bottasso
JournalMedicina (Medicina (B Aires)) Vol. 54 Issue 3 Pg. 265-71 ( 1994) ISSN: 0025-7680 [Print] Argentina
Vernacular TitleEl interferon gamma com estrategia immunológica para el tratamiento de la leishmaniasis humana.
PMID7854095 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Interferon-gamma
  • Antimony
Topics
  • Adolescent
  • Adult
  • Antimony (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Interferon-gamma (therapeutic use)
  • Leishmaniasis, Mucocutaneous (therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: